ArticleThe international journal of biostatistics2010
Targeted maximum likelihood based causal inference: Part I.
Article in The international journal of biostatistics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 236 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
236 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patientdata meta-analysis.Statistical methods in medical research · 2022Pooled it
- The Relationship of Pain Reduction With Prevention of Knee Replacement Under Dynamic Intervention Strategies.Arthritis & rheumatology (Hoboken, N.J.) · 2022Trial
- Helped into Harm: Mediation of a Housing Voucher Intervention on Mental Health and Substance Use in Boys.Epidemiology (Cambridge, Mass.) · 2021Trial
- Health Center-Based Community-Supported Agriculture: An RCT.American journal of preventive medicine · 2019Trial
- Composition or Context: Using Transportability to Understand Drivers of Site Differences in a Large-scale Housing Experiment.Epidemiology (Cambridge, Mass.) · 2018Trial
- Potential role of platelet-derived growth factor D in atherosclerotic cardiovascular disease risk.iScience · 2026Article
- High Pesticide Exposure Events and Self-Reported and Measured Olfactory Dysfunction.JAMA otolaryngology-- head & neck surgery · 2026Article
- Cost-effectiveness of the IMPALA monitoring system for hospitalised children in low-resource settings: a pragmatic before-and-after study.BMJ paediatrics open · 2026Article
- CIT-Lasso: a scalable approach beyond guilty by association for identifying causal variants from genome-wide summary statistics.Genome biology · 2026Article
- Article
- Article
- Constructing targeted minimum loss/maximum likelihood estimators: a simple illustration to build intuition.American journal of epidemiology · 2026Article
- Inference on summaries of a model-agnostic longitudinal variable importance trajectory with application to suicide prevention.The annals of applied statistics · 2026Article
- Comparing Care Coordination and Food Assistance Referrals to Improve Diabetes Outcomes: A Cohort Study.Journal of general internal medicine · 2026Article
- Mediation of chronic pain and disability on opioid use disorder risk by pain management practices among adult Medicaid patients, 2016-2019.American journal of epidemiology · 2026Article
- Nephrologist Affiliation With Dialysis Facilities and Patient Trajectories in End-Stage Kidney Disease.JAMA network open · 2026Article
- Long-term dynamic effect of body mass index on adverse cardiovascular outcomes with targeted maximum likelihood estimation method: result from the KNOW-CKD study.Scientific reports · 2026Article
- Physical activity across mid-life and mortality outcomes in Australian women: A target trial emulation using a prospective cohort.PLoS medicine · 2026Article
- Characterizing patterns of opioid and stimulant use by route and associations with non-fatal overdose and xylazine use in people who have injected drugs from Baltimore, MD, 2023-2024.Drug and alcohol dependence reports · 2026Article
- Methodological and regulatory considerations for causal AI in drug development.NPJ digital medicine · 2026Review
176 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Given causal graph assumptions, intervention-specific counterfactual distributions of the data can be defined by the so called G-computation formula, which is obtained by carrying out these interventions on the likelihood of the data factorized according to the causal graph. The obtained G-computation formula represents the counterfactual distribution the data would have had if this intervention would have been enforced on the system generating the data. A causal effect of interest can now be defined as some difference between these counterfactual distributions indexed by different interventions. For example, the interventions can represent static treatment regimens or individualized treatment rules that assign treatment in response to time-dependent covariates, and the causal effects could be defined in terms of features of the mean of the treatment-regimen specific counterfactual outcome of interest as a function of the corresponding treatment regimens. Such features could be defined nonparametrically in terms of so called (nonparametric) marginal structural models for static or individualized treatment rules, whose parameters can be thought of as (smooth) summary measures of differences between the treatment regimen specific counterfactual distributions. In this article, we develop a particular targeted maximum likelihood estimator of causal effects of multiple time point interventions. This involves the use of loss-based super-learning to obtain an initial estimate of the unknown factors of the G-computation formula, and subsequently, applying a target-parameter specific optimal fluctuation function (least favorable parametric submodel) to each estimated factor, estimating the fluctuation parameter(s) with maximum likelihood estimation, and iterating this updating step of the initial factor till convergence. This iterative targeted maximum likelihood updating step makes the resulting estimator of the causal effect double robust in the sense that it is consistent if either the initial estimator is consistent, or the estimator of the optimal fluctuation function is consistent. The optimal fluctuation function is correctly specified if the conditional distributions of the nodes in the causal graph one intervenes upon are correctly specified. The latter conditional distributions often comprise the so called treatment and censoring mechanism. Selection among different targeted maximum likelihood estimators (e.g., indexed by different initial estimators) can be based on loss-based cross-validation such as likelihood based cross-validation or cross-validation based on another appropriate loss function for the distribution of the data. Some specific loss functions are mentioned in this article. Subsequently, a variety of interesting observations about this targeted maximum likelihood estimation procedure are made. This article provides the basis for the subsequent companion Part II-article in which concrete demonstrations for the implementation of the targeted MLE in complex causal effect estimation problems are provided.
Indexed as
Identifiers
21969992PMC3126670What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.